Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence

Hereditary Hemorrhagic Telangiectasia (HHT) and Survival: The Importance of Systematic Screening and Treatment in HHT Centers of Excellence

Hereditary hemorrhagic telangiectasia (HHT), an autosomal dominant disease, is characterized by telangiectases and arteriovenous malformations (AVMs). Untreated AVMs, especially in the lungs—pulmonary AVMs (PAVMs)—can result in morbidity with a decreased life expectancy. We have investigated whether...

Full description

Bibliographic Details
Main Authors: Els M. de Gussem, Steven Kroon, Anna E. Hosman, Johannes C. Kelder, Martijn C. Post, Repke J. Snijder, Johannes J. Mager
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Clinical Medicine
Subjects:
telangiectasia
hereditary hemorrhagic
vascular malformations
survival
life expectancy
Online Access:https://www.mdpi.com/2077-0383/9/11/3581

Internet

https://www.mdpi.com/2077-0383/9/11/3581

Similar Items